Correlation Between DSV Panalpina and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DSV Panalpina and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DSV Panalpina and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DSV Panalpina AS and Genmab AS, you can compare the effects of market volatilities on DSV Panalpina and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DSV Panalpina with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of DSV Panalpina and Genmab AS.

Diversification Opportunities for DSV Panalpina and Genmab AS

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between DSV and Genmab is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding DSV Panalpina AS and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and DSV Panalpina is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DSV Panalpina AS are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of DSV Panalpina i.e., DSV Panalpina and Genmab AS go up and down completely randomly.

Pair Corralation between DSV Panalpina and Genmab AS

Assuming the 90 days trading horizon DSV Panalpina AS is expected to under-perform the Genmab AS. But the stock apears to be less risky and, when comparing its historical volatility, DSV Panalpina AS is 1.9 times less risky than Genmab AS. The stock trades about -0.12 of its potential returns per unit of risk. The Genmab AS is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  149,250  in Genmab AS on December 29, 2024 and sell it today you would lose (12,850) from holding Genmab AS or give up 8.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

DSV Panalpina AS  vs.  Genmab AS

 Performance 
       Timeline  
DSV Panalpina AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days DSV Panalpina AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Genmab AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

DSV Panalpina and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DSV Panalpina and Genmab AS

The main advantage of trading using opposite DSV Panalpina and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DSV Panalpina position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind DSV Panalpina AS and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.